152 related articles for article (PubMed ID: 22155462)
21. Serum 25-hydroxyvitamin D (25-OH-D) in obese adolescents.
Garanty-Bogacka B; Syrenicz M; Goral J; Krupa B; Syrenicz J; Walczak M; Syrenicz A
Endokrynol Pol; 2011; 62(6):506-11. PubMed ID: 22144216
[TBL] [Abstract][Full Text] [Related]
22. Serum 25-hydroxyvitamin D is associated with insulin resistance independently of obesity in children ages 5-17.
Gün E; Uzun H; Bolu S; Arslanoğlu İ; Kocabay K
Prim Care Diabetes; 2020 Dec; 14(6):741-746. PubMed ID: 32616391
[TBL] [Abstract][Full Text] [Related]
23. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.
Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B
Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650
[TBL] [Abstract][Full Text] [Related]
24. Vitamin D Deficient Older Adults Are More Prone to Have Metabolic Syndrome, but Not to a Greater Number of Metabolic Syndrome Parameters.
Pott-Junior H; Nascimento CMC; Costa-Guarisco LP; Gomes GAO; Gramani-Say K; Orlandi FS; Gratão ACM; Orlandi AADS; Pavarini SCI; Vasilceac FA; Zazzetta MS; Cominetti MR
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32178228
[TBL] [Abstract][Full Text] [Related]
25. The relation of vitamin D deficiency with puberty and insulin resistance in obese children and adolescents.
Buyukinan M; Ozen S; Kokkun S; Saz EU
J Pediatr Endocrinol Metab; 2012; 25(1-2):83-7. PubMed ID: 22570955
[TBL] [Abstract][Full Text] [Related]
26. A cross-sectional study of vitamin D and insulin resistance in children.
Kelly A; Brooks LJ; Dougherty S; Carlow DC; Zemel BS
Arch Dis Child; 2011 May; 96(5):447-52. PubMed ID: 21335626
[TBL] [Abstract][Full Text] [Related]
27. Low serum 25(OH)D levels are assocıated to hıgher BMI and metabolic syndrome parameters in adult subjects in Turkey.
Tosunbayraktar G; Bas M; Kut A; Buyukkaragoz AH
Afr Health Sci; 2015 Dec; 15(4):1161-9. PubMed ID: 26958017
[TBL] [Abstract][Full Text] [Related]
28. National report on the association of serum vitamin D with cardiometabolic risk factors in the pediatric population of the Middle East and North Africa (MENA): the CASPIAN-III Study.
Kelishadi R; Ardalan G; Motlagh ME; Shariatinejad K; Heshmat R; Poursafa P; Fakhri M; Tajadini M; Taslimi M
Nutrition; 2014 Jan; 30(1):33-8. PubMed ID: 24290595
[TBL] [Abstract][Full Text] [Related]
29. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency.
Ardabili HR; Gargari BP; Farzadi L
Nutr Res; 2012 Mar; 32(3):195-201. PubMed ID: 22464806
[TBL] [Abstract][Full Text] [Related]
30. Effect of vitamin D3 seasonal supplementation with 1500 IU/day in north Italian children (DINOS study).
Mazzoleni S; Magni G; Toderini D
Ital J Pediatr; 2019 Jan; 45(1):18. PubMed ID: 30691521
[TBL] [Abstract][Full Text] [Related]
31. Serum 25-hydroxy vitamin d and insulin resistance, metabolic syndrome, and glucose intolerance among Arab Americans.
Pinelli NR; Jaber LA; Brown MB; Herman WH
Diabetes Care; 2010 Jun; 33(6):1373-5. PubMed ID: 20332348
[TBL] [Abstract][Full Text] [Related]
32. Serum 25-hydroxyvitamin D and insulin resistance in apparently healthy adolescents.
Choi DP; Oh SM; Lee JM; Cho HM; Lee WJ; Song BM; Rhee Y; Kim HC
PLoS One; 2014; 9(7):e103108. PubMed ID: 25072652
[TBL] [Abstract][Full Text] [Related]
33. Relations between obesity, insulin resistance, and 25-hydroxyvitamin D.
Lamendola CA; Ariel D; Feldman D; Reaven GM
Am J Clin Nutr; 2012 May; 95(5):1055-9. PubMed ID: 22440850
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D deficiency is associated with metabolic syndrome in postmenopausal women.
Schmitt EB; Nahas-Neto J; Bueloni-Dias F; Poloni PF; Orsatti CL; Petri Nahas EA
Maturitas; 2018 Jan; 107():97-102. PubMed ID: 29169589
[TBL] [Abstract][Full Text] [Related]
35. Vitamin D deficiency in obese children and its relationship to glucose homeostasis.
Olson ML; Maalouf NM; Oden JD; White PC; Hutchison MR
J Clin Endocrinol Metab; 2012 Jan; 97(1):279-85. PubMed ID: 22072738
[TBL] [Abstract][Full Text] [Related]
36. Relationship between the Finnish Diabetes Risk Score (FINDRISC), vitamin D levels, and insulin resistance in obese subjects.
Lima-Martínez MM; Arrau C; Jerez S; Paoli M; González-Rivas JP; Nieto-Martínez R; Iacobellis G
Prim Care Diabetes; 2017 Feb; 11(1):94-100. PubMed ID: 27914905
[TBL] [Abstract][Full Text] [Related]
37. Vitamin D in children with growth hormone deficiency due to pituitary stalk interruption syndrome.
Delecroix C; Brauner R; Souberbielle JC
BMC Pediatr; 2018 Jan; 18(1):11. PubMed ID: 29368588
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of vitamin D deficiency and its association with metabolic derangements among children with obesity.
Adikaram SGS; Samaranayake DBDL; Atapattu N; Kendaragama KMDLD; Senevirathne JTN; Wickramasinghe VP
BMC Pediatr; 2019 Jun; 19(1):186. PubMed ID: 31176378
[TBL] [Abstract][Full Text] [Related]
39. Effect of high-dose vitamin D supplementation in combination with weight loss diet on glucose homeostasis, insulin resistance, and matrix metalloproteinases in obese subjects with vitamin D deficiency: a double-blind, placebo-controlled, randomized clinical trial.
Aliashrafi S; Ebrahimi-Mameghani M; Jafarabadi MA; Lotfi-Dizaji L; Vaghef-Mehrabany E; Arefhosseini SR
Appl Physiol Nutr Metab; 2020 Oct; 45(10):1092-1098. PubMed ID: 31874050
[TBL] [Abstract][Full Text] [Related]
40. Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome.
Fu J; Hou C; Li L; Feng D; Li G; Li M; Li C; Gao S; Li M
Cardiovasc Diabetol; 2016 Oct; 15(1):142. PubMed ID: 27716289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
